12 Health Care Stocks Moving In Friday's After-Market Session

Akanda Corp
Basel Medical Group Ltd
CapsoVision, Inc.
Cadrenal Therapeutics, Inc.
Forum Markets, Incorporated

Akanda Corp

AKAN

0.00

Basel Medical Group Ltd

BMGL

0.00

CapsoVision, Inc.

CV

0.00

Cadrenal Therapeutics, Inc.

CVKD

0.00

Forum Markets, Incorporated

FRMM

0.00

Gainers

  • Theriva Biologics (AMEX:TOVX) shares moved upwards by 47.5% to $0.38 during Friday's after-market session. The company's market cap stands at $11.5 million.
  • Psyence Biomedical (NASDAQ:PBM) stock increased by 16.31% to $8.84. The company's market cap stands at $6.0 million.
  • VivoSim Labs (NASDAQ:VIVS) stock rose 6.21% to $1.71. The company's market cap stands at $4.3 million.
  • Cadrenal Therapeutics (NASDAQ:CVKD) stock rose 5.74% to $5.52. The market value of their outstanding shares is at $11.3 million.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) shares increased by 5.38% to $4.89. The market value of their outstanding shares is at $356.0 million.
  • Basel Medical Group (NASDAQ:BMGL) shares rose 5.06% to $0.6. The company's market cap stands at $11.2 million.

Losers

  • SBC Medical Group Holding (NASDAQ:SBC) stock fell 11.4% to $3.98 during Friday's after-market session. The company's market cap stands at $453.3 million.
  • VolitionRX (AMEX:VNRX) shares fell 8.79% to $0.16. The market value of their outstanding shares is at $23.8 million.
  • Lunai Bioworks (NASDAQ:LNAI) shares declined by 8.23% to $0.32. The company's market cap stands at $11.0 million.
  • CapsoVision (NASDAQ:CV) stock declined by 7.66% to $5.55. The market value of their outstanding shares is at $269.1 million.
  • Akanda (NASDAQ:AKAN) stock declined by 7.63% to $3.27. The company's market cap stands at $1.7 million.
  • Forum Markets (NASDAQ:FRMM) stock declined by 6.76% to $4.0. The market value of their outstanding shares is at $48.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.